Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Sep;79(18):5666–5670. doi: 10.1073/pnas.79.18.5666

Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

R F Irie, L L Sze, R E Saxton
PMCID: PMC346965  PMID: 6291057

Abstract

We established two long-term human B-lymphoblastoid cell lines (L55 and L72) transformed by Epstein-Barr virus that produced IgM kappa antibodies to the human tumor antigen, OFA-I. Periphral blood lymphocytes obtained from melanoma patients were used as the source of the B lymphocytes. Antibody specificity was determined by the immune adherence assay using various human cancer and noncancer tissues as targets. L55 antibody (designated anti-OFA-I-1) reacted with a variety of human tumor types whereas L72 antibody (designated anti-OFA-I-2) reacted only with tumor cells of neuroectodermal origin (melanoma, glioma, and neuroblastoma). The levels of IgM detected in the spent medium of 1 X 10(6) L55 and L72 cells were 4 and 9 micrograms/ml, respectively, by radioimmunoassay.

Full text

PDF
5666

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bumol T. F., Reisfeld R. A. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1245–1249. doi: 10.1073/pnas.79.4.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Danon Y. L., Seeger R. C., Maidman J. E. Fetal neural antigens on human neuroblastoma cells. J Immunol. 1980 Jun;124(6):2925–2929. [PubMed] [Google Scholar]
  3. Dippold W. G., Lloyd K. O., Li L. T., Ikeda H., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6114–6118. doi: 10.1073/pnas.77.10.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Irie K., Irie R. F., Morton D. L. Evidence for in vivo reaction of antibody and complement to surface antigens of human cancer cells. Science. 1974 Nov 1;186(4162):454–456. doi: 10.1126/science.186.4162.454. [DOI] [PubMed] [Google Scholar]
  5. Irie R. F., Giuliano A. E., Morton D. L. Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man. J Natl Cancer Inst. 1979 Aug;63(2):367–373. [PubMed] [Google Scholar]
  6. Irie R. F., Irie K., Morton D. L. A membrane antigen common to human cancer and fetal brain tissues. Cancer Res. 1976 Sep;36(9 Pt 2):3510–3517. [PubMed] [Google Scholar]
  7. Irie R. F., Jones P. C., Morton D. L., Sidell N. In vitro production of human antibody to a tumour-associated foetal antigen. Br J Cancer. 1981 Aug;44(2):262–266. doi: 10.1038/bjc.1981.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jones P. C., Sze L. L., Liu P. Y., Morton D. L., Irie R. F. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst. 1981 Feb;66(2):249–254. [PubMed] [Google Scholar]
  9. Kennett R. H., Gilbert F. Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain. Science. 1979 Mar 16;203(4385):1120–1121. doi: 10.1126/science.424740. [DOI] [PubMed] [Google Scholar]
  10. Koprowski H., Steplewski Z., Herlyn D., Herlyn M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3405–3409. doi: 10.1073/pnas.75.7.3405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kozbor D., Roder J. C. Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J Immunol. 1981 Oct;127(4):1275–1280. [PubMed] [Google Scholar]
  12. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  13. Levy R., Dilley J., Fox R. I., Warnke R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6552–6556. doi: 10.1073/pnas.76.12.6552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Levy R., Dilley J., Fox R. I., Warnke R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6552–6556. doi: 10.1073/pnas.76.12.6552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  16. Olsson L., Kaplan H. S. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5429–5431. doi: 10.1073/pnas.77.9.5429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pierce S. K., Klinman N. R. The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses. J Exp Med. 1975 Nov 1;142(5):1165–1179. doi: 10.1084/jem.142.5.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rees W. V., Irie R. F., Morton D. L. Oncofetal antigen-I: distribution in human tumors. J Natl Cancer Inst. 1981 Sep;67(3):557–562. [PubMed] [Google Scholar]
  19. Saxton R. E., Irie R. F., Ferrone S., Pellegrino M. A., Morton D. L. Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients. Int J Cancer. 1978 Mar 15;21(3):299–306. doi: 10.1002/ijc.2910210308. [DOI] [PubMed] [Google Scholar]
  20. Shiku H., Takahashi T., Oettgen H. F. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med. 1976 Oct 1;144(4):873–881. doi: 10.1084/jem.144.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sidell N., Irie R. F., Morton D. L. Oncofoetal antigen I: a target for immune cytolysis of human cancer. Br J Cancer. 1979 Dec;40(6):950–953. doi: 10.1038/bjc.1979.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Steinitz M., Koskimies S., Klein G., Mäkelä O. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. J Clin Lab Immunol. 1979 Apr;2(1):1–7. [PubMed] [Google Scholar]
  23. Wikstrand C. J., Bigner D. D. Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies. Cancer Res. 1982 Jan;42(1):267–275. [PubMed] [Google Scholar]
  24. Wikstrand C. J., Bigner D. D. Surface antigens of human glioma cells shared with normal adult and fetal brain. Cancer Res. 1979 Aug;39(8):3235–3243. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES